Core Scientific, Inc. Common Stock (CORZ) — Capital Reinvestment Ratio
Core Scientific, Inc. Common Stock (CORZ) has a Capital Reinvestment Ratio of 1.56x as of March 2026, meaning it reinvests 2% of its operating cash flow ($249.88 Million) in capital expenditures ($389.23 Million). See Core Scientific, Inc. Common Stock (CORZ) balance sheet quality index to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Core Scientific, Inc. Common Stock Capital Reinvestment Ratio (2022–2025)
This chart tracks Core Scientific, Inc. Common Stock's Capital Reinvestment Ratio across 4 annual periods. Check CORZ capex plus investments ratio to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Core Scientific, Inc. Common Stock (2022–2025)
Year-by-year Capital Reinvestment Ratio for Core Scientific, Inc. Common Stock from 2022 to 2025. For live market cap and broader valuation context, see Core Scientific, Inc. Common Stock stock valuation.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 2.62x | $278.25 Million | $729.00 Million | ▲ +18.3% |
| 2024 | 2.21x | $42.90 Million | $94.96 Million | ▲ +791.9% |
| 2023 | 0.25x | $65.11 Million | $16.16 Million | ▼ -91.5% |
| 2022 | 2.93x | $205.19 Million | $601.66 Million | — |